PGR and ovarian neoplasm: These data are consistent with the prolonged survival described in EnOCs with >1% PR-positive nuclei by the Ovarian Tumor Tissue Analysis consortium [21], identifying 10-year patient survival of around 80%, 60–65% and 50% in those demonstrating ≥50%, 1–50% and <1% PR positive tumor cell nuclei.